AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$321,716,381
Investments
65%
Property, Plant, & Equipment (net)
20%
Receivables (Non-Related)
10%
Cash & Equivalents
2%
Prepaid Expenses
2%
Other Assets
1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$111,219,799
Deferred Revenue
47%
Notes Payable / Debt (Non-Related)
36%
Payables & Accruals
13%
Other Liabilities
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$9,395,785
$6,471,398
-31%
Receivables (Non-Related)
$12,675,262
$31,168,008
+146%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$8,339,401
$5,675,802
-32%
Investments
$208,311,312
$210,045,111
+1%
Property, Plant, & Equipment (net)
$53,189,639
$64,850,297
+22%
Other Assets
$4,627,040
$3,505,765
-24%
Total Assets
$296,538,439
$321,716,381
+8%
Liabilities
2023
2024
Change
Payables & Accruals
$11,247,077
$14,760,833
+31%
Grants Payable
-
-
-
Deferred Revenue
$52,717,228
$52,537,124
0%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$43,521,229
$40,538,859
-7%
Related-Party Payables
-
-
-
Other Liabilities
$5,206,417
$3,382,983
-35%
Total Liabilities
$112,691,951
$111,219,799
-1%
Net assets
2023
2024
Change
Restricted Net Assets
$288,740
$109,851
-62%
Unrestricted Net Assets
$183,557,748
$210,386,731
+15%
Net assets
2023
2024
Change
Net assets
+$183,846,488
+$210,496,582
+14%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)